The international journal of medical robotics + computer assisted surgery : MRCAS · 2025
Comparison of Robotic and Laparoscopic Pancreatic Surgery Outcomes: A Retrospective Cohort Study With Propensity Score Matching and Subgroup Analysis of Pancreatic Malignancies and Moderate to High-Risk Pancreatic Fistulas.
СтатьяСравнительное исследованиеНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Yu Min, Zhong Wentao, Zhang Feng, Hong Weifeng, Yuan Yuan, Zou Changgui, Lin Qing, Chen Rufu
Аннотация
BACKGROUND: This study compares robotic-assisted pancreatic surgery (R-PS) and laparoscopic pancreatic surgery (L-PS) outcomes in patients with pancreatic malignancies and medium- to high-risk pancreatic fistulas.
MATERIALS AND METHODS: A retrospective cohort study was conducted at Guangdong Provincial People's Hospital (2021-2023). The primary endpoints were major complications (Clavien-Dindo grade ≥ III) and postoperative morbidity.
RESULTS: 200 R-PS and 400 L-PS patients were included, with 163 pairs matched. R-PS showed lower conversion rates (2.5% vs. 17.2%, p < 0.001), less blood loss (119 vs. 179 mL, p = 0.013), and faster function recovery (8.2 vs. 9.6 days, p = 0.038). Postoperatively, R-PS had fewer pancreatic fistulas in malignant (4.1% vs. 32.6%, p < 0.001) and moderate to high-risk cases (8.3% vs. 16.7%, p = 0.026). R-PS benefits are not procedure-specific.
CONCLUSION: R-PS offers advantages in blood loss, complications, and fistula prevention, suggesting it may be preferable for complex pancreatic surgeries.
MATERIALS AND METHODS: A retrospective cohort study was conducted at Guangdong Provincial People's Hospital (2021-2023). The primary endpoints were major complications (Clavien-Dindo grade ≥ III) and postoperative morbidity.
RESULTS: 200 R-PS and 400 L-PS patients were included, with 163 pairs matched. R-PS showed lower conversion rates (2.5% vs. 17.2%, p < 0.001), less blood loss (119 vs. 179 mL, p = 0.013), and faster function recovery (8.2 vs. 9.6 days, p = 0.038). Postoperatively, R-PS had fewer pancreatic fistulas in malignant (4.1% vs. 32.6%, p < 0.001) and moderate to high-risk cases (8.3% vs. 16.7%, p = 0.026). R-PS benefits are not procedure-specific.
CONCLUSION: R-PS offers advantages in blood loss, complications, and fistula prevention, suggesting it may be preferable for complex pancreatic surgeries.